Clin2
NCT07241533Possibly a fitRecruiting

Asiaticoside for overweight and obesity

Overweight , Obesity

Part of Hormones & metabolism clinical trials.

This study tests whether a natural compound called asiaticoside can help people who are overweight or have obesity. If you are an adult with a body mass index (BMI) between 24 and 45, you may be able to join and see if the treatment helps with weight loss.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • Your body mass index (BMI) must be between 24 and 45.
  • You cannot have certain serious health conditions like active tuberculosis, cancer, or HIV.
  • You cannot have severe liver or kidney problems.
  • You cannot have had a heart attack, stroke, or major heart condition in the last 6 months.
  • You must not smoke or have used tobacco in the past 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07668401Not yet recruiting· Phase 3
Weight loss study for adults in Asia

This study tests an investigational medicine called Zenagamtide to see if it helps people with excess body weight lose weight. It is specifically for adults in Asia who do not have diabetes and have not taken certain weight-loss or diabetes medicines before.

Surat, Gujarat
NCT07743463Recruiting· Phase 3
Daily pill for weight loss in adults with excess weight or weight-related health issues

This study tests a once-daily pill called ASC30 to help adults with obesity or overweight who also have conditions like high blood pressure, sleep apnea, or heart disease lose weight. The pill may work by affecting appetite and blood sugar, and the study aims to see how effective and safe it is.

Birmingham, Alabama
NCT07629544Recruiting· Phase 3
Testing DA-302168S for weight loss in overweight and obese adults

This study tests a new medication called DA-302168S to help people lose weight. You may qualify if you're overweight or obese and meet certain health requirements.

Beijing
NCT07743450Recruiting· Phase 3
Daily oral medication for weight loss in adults with obesity and type 2 diabetes

This study tests a once-a-day pill for adults who are overweight or have obesity and also have type 2 diabetes. The goal is to see if the medication helps with weight loss and improves blood sugar control.

Birmingham, Alabama
NCT07511205Recruiting· Phase 1
Study of AZD1043 for overweight or obesity

This trial tests a new medicine called AZD1043 in healthy adults who are overweight or have obesity. It aims to see if the medicine is safe and how the body handles it.

Glendale, California
NCT07775404Recruiting· Phase 3
Weight loss medication for Asian adults with obesity or overweight

This study tests an investigational medication called elecoglipron for weight loss in Asian adults who are overweight or have obesity, with or without type 2 diabetes. It may help participants lose weight and improve health.

Baotou

Hear when a new Overweight , Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.